Twist Bioscience (TWST) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Ngs ToolsSynthetic GenesAntibody DiscoveryOligo PoolsDna And Biopharma Libraries
025M50M75M100M125M150M175M200MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue by Geography

AmericasEMEAAsia Pacific
025M50M75M100M125M150M175M200MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025M50M75M100M125M150M175M200MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
01122344556687990Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
025M50M75M100M125M150M175M200MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

EBITDA

EBITDA
-50M-39M-28M-16M-5M6M18M29M40MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

EPS

EPSEPS Diluted
000001111Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue Variation (%)

Revenue Variation
012345678Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0255075100125150175200Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue YoY Variation (%)

Revenue YoY Variation
048111519222630Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0815223038455260Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Price-to-Earning Ratio

P/E Ratio
-20-12-521018253240Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
0918263544526170Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
011M22M34M45M56M68M79M90MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
001122233Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
038M75M112M150M188M225M262M300MQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
🏦 Balance Sheet
📈 Key Metrics